---
title: "Innovative drug concept rebounds after hitting the bottom, Junshi Biosciences and others rise over 5%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252142016.md"
description: "Innovative drug concept stocks rebound after hitting the bottom, Beilu Pharma, JLPC, Lepu Medical, Junshi Biosciences, JINGXIN, and Cosunter all rise over 5%"
datetime: "2025-08-08T02:29:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252142016.md)
  - [en](https://longbridge.com/en/news/252142016.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252142016.md)
---

# Innovative drug concept rebounds after hitting the bottom, Junshi Biosciences and others rise over 5%

Innovative drug concept stocks rebound after hitting bottom, Beilu Pharma, JLPC, Lepu Medical, JUNSHI BIO, JINGXIN, and Cosunter all rise over 5%

### Related Stocks

- [002020.CN](https://longbridge.com/en/quote/002020.CN.md)
- [300436.CN](https://longbridge.com/en/quote/300436.CN.md)
- [688180.CN](https://longbridge.com/en/quote/688180.CN.md)
- [01877.HK](https://longbridge.com/en/quote/01877.HK.md)
- [300016.CN](https://longbridge.com/en/quote/300016.CN.md)
- [600513.CN](https://longbridge.com/en/quote/600513.CN.md)
- [300003.CN](https://longbridge.com/en/quote/300003.CN.md)

## Related News & Research

- [Cold-Chain Provider Shanghai Shengsheng Renews Hong Kong Listing Plan](https://longbridge.com/en/news/294397065.md)
- [Sleep apnea pill developer Apnimed prices upsized IPO at $16, the high end of the range](https://longbridge.com/en/news/294514935.md)
- [National Medical Care Company: Record 2Q 2026 results driven by volume growth and GOSI rebound; expansion and digital initiatives ongoing](https://longbridge.com/en/news/294384333.md)
- [APR Technologies’ thermal management technology qualifies for NATO Rapid Adoption Service procurement](https://longbridge.com/en/news/294463679.md)
- [Orion Diversified Holding buys 0.61% working interest in North Dakota Wiley Glenburn Unit](https://longbridge.com/en/news/293955142.md)